Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The anti-inflammatory pathway is a complex network of molecular and cellular mechanisms that actively suppress or resolve inflammation, maintaining tissue homeostasis and preventing excessive immune responses. It involves neuro-immune circuits like the cholinergic anti-inflammatory pathway (CAP), neuroendocrine regulation via the HPA axis and SNS, and cytokine networks mediated by anti-inflammatory molecules such as IL-10 and TGFβ. Dysregulation contributes to chronic inflammatory diseases.
Various, depending on the targeted component. NSAIDs inhibit COX enzymes, glucocorticoids suppress gene transcription, JAK inhibitors block cytokine signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-inflammatory Pathway.